NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $238,862 | +0.9% | 2,345 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $236,634 | +14.8% | 2,345 | +4.6% | 0.01% | +25.0% |
Q1 2023 | $206,172 | -3.0% | 2,241 | -4.4% | 0.00% | -20.0% |
Q4 2022 | $212,549 | -0.2% | 2,343 | -3.3% | 0.01% | +25.0% |
Q1 2022 | $213,000 | +3.9% | 2,424 | +3.5% | 0.00% | 0.0% |
Q4 2021 | $205,000 | -5.1% | 2,343 | -1.1% | 0.00% | 0.0% |
Q2 2021 | $216,000 | +6.9% | 2,368 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $202,000 | -21.7% | 2,368 | -13.3% | 0.01% | -16.7% |
Q4 2020 | $258,000 | +16.7% | 2,732 | +7.4% | 0.01% | 0.0% |
Q3 2020 | $221,000 | -0.5% | 2,544 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $222,000 | -4.7% | 2,544 | -10.2% | 0.01% | -25.0% |
Q1 2020 | $233,000 | -21.8% | 2,832 | -10.0% | 0.01% | 0.0% |
Q4 2019 | $298,000 | +10.8% | 3,145 | +1.7% | 0.01% | +14.3% |
Q3 2019 | $269,000 | -8.2% | 3,092 | -3.6% | 0.01% | -12.5% |
Q2 2019 | $293,000 | +18.1% | 3,206 | +24.2% | 0.01% | +14.3% |
Q1 2019 | $248,000 | +22.2% | 2,581 | +8.9% | 0.01% | 0.0% |
Q4 2018 | $203,000 | – | 2,369 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
Elefante Mark B | 5,619 | $417,000 | 3.78% |
SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |